Icon

RIVFLOZA (NDA215842)- (EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML),EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML),EQ 160MG BASE/ML (EQ 160MG BASE/ML))

NEDOSIRAN SODIUM NOVO
EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML),EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML),EQ 160MG BASE/ML (EQ 160MG BASE/ML)
No No
2038-Oct-12 2028-Sep-29
None None
None No
RIVFLOZA is an LDHA-directed small interfering RNA indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥ 30 mL/min/1.73 m2.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML) ** ** - - -
EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML) ** ** - - -
EQ 160MG BASE/ML (EQ 160MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.